CA-125 and ovarian cancer: understanding the blood test

CA-125 is a protein measured in blood. Some ovarian cancers release it, so a raised level can add information when symptoms, examination findings, or imaging raise concern. However, menstruation, pregnancy, endometriosis, fibroids, pelvic infection, and non-gynaecological conditions can also raise it. Some ovarian cancers do not produce much CA-125. For these reasons, clinicians interpret the value alongside personal history, menopausal status, symptoms, examination, and imaging rather than treating it as a yes-or-no cancer test. A trend may be more informative than an isolated result when the marker is being used during established cancer care.

Discuss the result with the clinician who ordered it instead of interpreting the laboratory flag alone. They may review persistent bloating, pelvic or abdominal discomfort, feeling full quickly, appetite changes, or urinary changes and decide whether pelvic ultrasound or specialist assessment is appropriate. If ovarian cancer has already been diagnosed, CA-125 may be checked over time to help assess response or investigate a possible return of disease, provided it was informative for that cancer. A change in the marker does not automatically determine treatment; imaging, symptoms, examination, and treatment goals remain relevant.

Arrange a medical review if bloating, pelvic or abdominal pain, early fullness, reduced appetite, or urinary changes are new, persistent, or becoming more noticeable. Seek urgent care for severe or rapidly worsening abdominal pain, repeated vomiting with inability to keep fluids down, fainting, marked shortness of breath, or a suddenly swollen painful leg. Urgency is based on the symptoms and your overall condition, not on a CA-125 value alone. If you are receiving cancer treatment, use the treatment team's urgent contact instructions for fever or other acute changes.

Ask why CA-125 was requested, which features of your history affect its interpretation, and whether comparison with an earlier result is useful. Find out whether you need ultrasound, examination, repeat testing, or referral to a gynaecology team. After a cancer diagnosis, ask whether this marker reflects your particular tumour and how blood results will be considered alongside scans, symptoms, and treatment decisions.